Company Dossier · Health Care
Ensign Group
- Russell 1000
- MidCap 400
What Ensign Group is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $5.46 billion, up 19% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to December 31, 2019: $0.12 billion, down 25% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to December 31, 2019: $0.07 billion, up 40% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to December 31, 2025: $0.02 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (July 28, 2026): sentiment 0.80 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.90 of 1.Palanor Discourse
- Guidance in the last 90 days: 2 outlook figures raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
- Latest annual report (filed February 4, 2026): 2 risk factors added, 3 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $0.1 million on the open market.SEC Form 4
- 550 institutional managers reported a position at June 30, 2026 (−25 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 16 (10 a year earlier).U.S. Department of Labor (OFLC)
Company Posture
How Company Posture is measured →Company Posture covers S&P 500 companies.
Credit
How these are built →No bond term sheets or tagged debt on file for Ensign Group yet.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Ensign Group, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- PositiveEnsign Group (ENSG) Expands Washington State Presence with Acquisition of Four Skilled Nursing Facilities
gurufocus.com · via Marketaux · Oct 2, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 20, 2026LobbyingLobbying report (BGR GOVERNMENT AFFAIRS)third_quarter 2026 · $0.1 million
- Sep 16, 2026LobbyingLobbying report (BGR GOVERNMENT AFFAIRS)third_quarter 2026
- Aug 20, 20268-KMaterial agreement signedItem 1.01
- May 18, 20268-KShareholder vote resultsItem 5.07
- Feb 4, 202610-KAnnual report (10-K)2 risk factors added, 3 removed
- Aug 26, 20258-KDirector or officer changeItem 5.02
- Jun 20, 20258-KDirector or officer changeItem 5.02
- May 20, 20258-KShareholder vote resultsItem 5.07
- Feb 5, 202510-KAnnual report (10-K)1 risk factors added, 3 removed
- Oct 21, 20248-KDirector or officer changeItem 5.02
- Feb 1, 202410-KAnnual report (10-K)3 risk factors added, 4 removed
Peers
Companies in the same sector in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Incyte INCY | $5.4B | — | Mar 31, 2026 |
| ResMed| RMD | $5.7B | $1.6B | Jun 30, 2026 |
| Elanco ELAN | $5.0B | $0.4B | Jun 30, 2026 |
| Dexcom DXCM | $5.0B | $1.4B | Jun 30, 2026 |
| Steris STE | $6.0B | $0.9B | Jun 30, 2026 |
| Organon & Co. OGN | $6.1B | $0.6B | Jun 30, 2026 |
| Encompass Health EHC | $6.2B | $0.4B | Jun 30, 2026 |
| Waters Corporation WAT | $4.6B | — | Jul 4, 2026 |
Identity
- SEC CIK
- 1125376